Dr. James J. Lah, MD, PhD

Dr. Lah practices at Emory University Hospital in Atlanta, Georgia, part of Emory University.

Dr. Lah's NPI, 1952358582, was assigned on May 28, 2006. Dr. Lah graduated from Ohio State College of Medicine in 1992. Dr. Lah holds Georgia license 041863.

Dr. Lah's primary practice is Emory University Hospital, at 1364 Clifton Road, NE, Atlanta, GA 30322 in De Kalb County. The practice phone is (404) 686-8500.

Dr. Lah's primary practice is Emory University Hospital in Atlanta, Georgia, part of Emory University. Dr. Lah is also affiliated with Emory University Hospital Midtown. The medical group on file is Emory Clinic. Dmand AI also links Dr. Lah to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lah practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Lah's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Lah is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Lah's licenses on file in 3 states: Georgia, North Carolina and Alabama.

Dmand AI lists non-alzheimer's dementia (chronic) and sleep apnea among the conditions Dr. Lah treats.

CMS data shows 149 Medicare services from Dr. Lah across 5 procedure codes in 2024, for 100 Medicare patients. Medicare paid $15,806 for them. Every service was in an office.

CMS counts 100 Medicare patients who saw Dr. Lah in 2024. The largest group is 75 to 84, with 53 patients. 75% of them have high cholesterol, and 70% have high blood pressure. Their average risk score is 0.96, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lah's median patient age at 77, with 56% women.

In 2024, Dr. Lah wrote 924 Medicare Part D claims for 184 patients. 98% of them were for generic drugs. CMS names the drug for 851 of them, across 13 drugs with 11 or more claims each, at $21,620 in total drug cost. In 2023, CMS named 949 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Lah for performance year 2024, reported through an alternative payment model (APM). Dr. Lah accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lah as offering telehealth.

Dmand AI links 176 papers to Dr. Lah, published from 2003 to 2025. 2024 was the busiest year, with 22. The most frequent topics are Alzheimer Disease, Brain and Proteomics. Dr. Lah has published most often in Mol Neurodegener. Dr. Lah's most frequent co-authors are Thomas S. Wingo, MD, Chadwick McKinley Hales, MD, PhD and David A. Bennett, MD.

Dmand AI links Dr. Lah to 6 clinical trials. 2 are still active or recruiting. Conditions studied include Alzheimer Disease, Cognition Disorders and Cognitive Dysfunction. Emory University sponsors the most, 3. Open Payments lists research payments to Dr. Lah that name 2 trials.

CMS Open Payments shows 5 general payments to Dr. Lah from 3 drug and device companies from 2022 to 2025. Speaker and faculty fees make up the largest share, 96% of the total. Roche Diagnostics Corporation paid the most, $2,900. It also lists 3 research payments totaling $10,830 from 2017 to 2022, naming 2 clinical trials.

Dmand AI lists 5 awards for Dr. Lah, most recently Outstanding Postdoc Mentor Award in 2012.

Dr. Lah graduated from Ohio State College of Medicine in 1992.

Dr. Lah is in network with 9 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.